K. Getty

发表

Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.

P. D. Cook, J. Tomassini, M. Maccoss, 2004, Journal of medicinal chemistry.

Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.

D. Hazuda, J. Krueger, M. Parniak, 2005, Biochemistry.

A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties

Giovanni Migliaccio, D. Hazuda, J. Tomassini, 2004, Antimicrobial Agents and Chemotherapy.

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro*

D. Hazuda, R. Cortese, J. Tomassini, 2003, Journal of Biological Chemistry.

Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.

Quanlai Song, Jie Xia, Daniel R McMasters, 2004, Journal of medicinal chemistry.

Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs*

Lawrence C Kuo, Giovanni Migliaccio, L. Kuo, 2003, The Journal of Biological Chemistry.

Inhibitory Effect of 2′-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon Cells

J. Tomassini, M. Maccoss, G. Migliaccio, 2005, Antimicrobial Agents and Chemotherapy.

An in vitro Flaviviridae replicase system capable of authentic RNA replication.

J. Tomassini, L. Gan, R. Lafemina, 2003, Virology.

Identification of potent inhibitors of the sortilin-progranulin interaction.

Gregory T O'Donnell, P. Coleman, M. Ziebell, 2020, Bioorganic & medicinal chemistry letters.

Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads

G. McGaughey, E. Ottinger, M. Citron, 2010, The Journal of Biological Chemistry.

LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease

Shane D. Marine, Amy S. Espeseth, Min Xu, 2006, Proceedings of the National Academy of Sciences.

The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug design.

Deping Wang, Sujata Sharma, W. Shipe, 2017, Bioorganic & medicinal chemistry letters.